Neuromodulation Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Technology (External (Non-Invasive) Neuromodulation and Internal Neuromodulation); End User (Hospitals, Clinics and Home Healthcare) and Geography
Report Code: TIPHE100001415 No. of Pages: 150 Category: Medical Device Status: Upcoming
Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation.
Rising cases of neurological disorders and growth in the geriatric population is expected to propel the neuromodulation market growth in the coming years. Technological advancements and the rising cases of Alzheimer and Parkinson's disease is expected to offer significant growth opportunities in the neuromodulator market during the forecast period.
The "Global Neuromodulation Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global neuromodulation market with detailed market segmentation by technology, end user, and geography. The global neuromodulation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global neuromodulation market is segmented on the basis of technology end user. Based on technology, the neuromodulation market is segmented as, external (non-invasive) neuromodulation and internal neuromodulation. The segment of external (non-invasive) neuromodulation is further classified as, respiratory electrical stimulation (RES), transcutaneous electrical nerve stimulation (TENS) and transcranial magnetic stimulation (TMS). Internal neuromodulation is further classified as, deep brain stimulation (DBS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS). Based on end user, neuromodulation market is segmented as, hospitals, clinics and home healthcare.
The neuromodulation market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neuromodulation market based technology, and end user. It also provides market size and forecast till 2027 for overall neuromodulation market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neuromodulation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the neuromodulation market in the coming years, owing to increasing ageing population in the US and availability of better healthcare services. The demand for neuromodulation market in Asia Pacific is expected to witness significant growth during the forecast period, due to increasing prevalence of neurological disorders in the population.
The neuromodulation market report analyzes factors affecting neuromodulation market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The neuromodulation market report also includes the profiles of key neuromodulation manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the neuromodulation market are Abbott, Boston Scientific Corporation, Integer Holdings Corporation, Magstim, Medtronic, NeuroPace, Inc., NeuroSigma, Inc., Nevro Corp., Synapse Biomedical Inc., and Soterix Medical Inc. among others.
Rising cases of neurological disorders and growth in the geriatric population is expected to propel the neuromodulation market growth in the coming years. Technological advancements and the rising cases of Alzheimer and Parkinson's disease is expected to offer significant growth opportunities in the neuromodulator market during the forecast period.
The "Global Neuromodulation Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global neuromodulation market with detailed market segmentation by technology, end user, and geography. The global neuromodulation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global neuromodulation market is segmented on the basis of technology end user. Based on technology, the neuromodulation market is segmented as, external (non-invasive) neuromodulation and internal neuromodulation. The segment of external (non-invasive) neuromodulation is further classified as, respiratory electrical stimulation (RES), transcutaneous electrical nerve stimulation (TENS) and transcranial magnetic stimulation (TMS). Internal neuromodulation is further classified as, deep brain stimulation (DBS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS). Based on end user, neuromodulation market is segmented as, hospitals, clinics and home healthcare.
The neuromodulation market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neuromodulation market based technology, and end user. It also provides market size and forecast till 2027 for overall neuromodulation market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neuromodulation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the neuromodulation market in the coming years, owing to increasing ageing population in the US and availability of better healthcare services. The demand for neuromodulation market in Asia Pacific is expected to witness significant growth during the forecast period, due to increasing prevalence of neurological disorders in the population.
The neuromodulation market report analyzes factors affecting neuromodulation market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The neuromodulation market report also includes the profiles of key neuromodulation manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the neuromodulation market are Abbott, Boston Scientific Corporation, Integer Holdings Corporation, Magstim, Medtronic, NeuroPace, Inc., NeuroSigma, Inc., Nevro Corp., Synapse Biomedical Inc., and Soterix Medical Inc. among others.
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. NEUROMODULATION MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Neuromodulation Market - By Technology
3.2.2. Neuromodulation Market - By End User
3.2.3. Neuromodulation Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. NEUROMODULATION MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. NEUROMODULATION MARKET - GLOBAL ANALYSIS
5.1. GLOBAL NEUROMODULATION MARKET OVERVIEW
5.2. GLOBAL NEUROMODULATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS
6. NEUROMODULATION MARKET- GLOBAL REGULATORY SCENARIO
6.1. OVERVIEW
6.2. NORTH AMERICA
6.3. EUROPE
6.4. ASIA PACIFIC
6.5. MIDDLE EAST & AFRICA
6.6. SOUTH AND CENTRAL AMERICA
7. NEUROMODULATION MARKET REVENUE AND FORECASTS TO 2027 - BY TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. EXTERNAL (NON-INVASIVE) NEUROMODULATION MARKET
7.3.1. Overview
7.3.2. External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3. Respiratory Electrical Stimulation (RES) Market
7.3.3.1. Overview
7.3.3.2. Respiratory Electrical Stimulation (RES) Market Revenue Forecasts and Analysis (US$ Mn)
7.3.4. Transcutaneous Electrical Nerve Stimulation (TENS) Market
7.3.4.1. Overview
7.3.4.2. Transcutaneous Electrical Nerve Stimulation (TENS) Market Revenue Forecasts and Analysis (US$ Mn)
7.3.5. Transcranial Magnetic Stimulation (TMS) Market
7.3.5.1. Overview
7.3.5.2. Transcranial Magnetic Stimulation (TMS) Market Revenue Forecasts and Analysis (US$ Mn)
7.4. INTERNAL NEUROMODULATION MARKET
7.4.1. Overview
7.4.2. Internal Neuromodulation Market Revenue Forecasts and Analysis (US$ Mn)
7.4.3. Deep Brain Stimulation (DBS) Market
7.4.3.1. Overview
7.4.3.2. Deep Brain Stimulation (DBS) Market Revenue Forecasts and Analysis (US$ Mn)
7.4.4. Sacral Nerve Stimulation (SNS) Market
7.4.4.1. Overview
7.4.4.2. Sacral Nerve Stimulation (SNS) Market Revenue Forecasts and Analysis (US$ Mn)
7.4.5. Gastric Electrical Stimulation (GES) Market
7.4.5.1. Overview
7.4.5.2. Gastric Electrical Stimulation (GES) Market Revenue Forecasts and Analysis (US$ Mn)
7.4.6. Spinal Cord Stimulation (SCS) Market
7.4.6.1. Overview
7.4.6.2. Spinal Cord Stimulation (SCS) Market Revenue Forecasts and Analysis (US$ Mn)
7.4.7. Vagus Nerve Stimulation (VNS) Market
7.4.7.1. Overview
7.4.7.2. Vagus Nerve Stimulation (VNS) Market Revenue Forecasts and Analysis (US$ Mn)
8. NEUROMODULATION MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. HOSPITALS MARKET
8.3.1. Overview
8.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
8.4. CLINICS MARKET
8.4.1. Overview
8.4.2. Clinics Market Revenue Forecasts and Analysis (US$ Mn)
8.5. HOME HEALTHCARE MARKET
8.5.1. Overview
8.5.2. Home Healthcare Market Revenue Forecasts and Analysis (US$ Mn)
9. NORTH AMERICA NEUROMODULATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. NORTH AMERICA NEUROMODULATION MARKET OVERVIEW
9.2. NORTH AMERICA NEUROMODULATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
9.3.1. North America External (Non-Invasive) Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
9.3.2. North America Internal Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
9.4. NORTH AMERICA NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.5. NORTH AMERICA NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
9.6. US MARKET OVERVIEW
9.6.1. US Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.6.1.1. US External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.6.1.2. US Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.6.2. US Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.7. CANADA MARKET OVERVIEW
9.7.1. Canada Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.7.1.1. Canada External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7.1.2. Canada Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7.2. Canada Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. MEXICO MARKET OVERVIEW
9.8.1. Mexico Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.8.1.1. Mexico External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.8.1.2. Mexico Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.8.2. Mexico Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10. EUROPE NEUROMODULATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. EUROPE NEUROMODULATION MARKET OVERVIEW
10.2. EUROPE NEUROMODULATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
10.3.1. Europe External (Non-Invasive) Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
10.3.2. Europe Internal Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
10.4. EUROPE NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.5. EUROPE NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
10.6. UK MARKET OVERVIEW
10.6.1. UK Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.6.1.1. UK External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.6.1.2. UK Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.6.2. UK Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.7. GERMANY MARKET OVERVIEW
10.7.1. Germany Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.7.1.1. Germany External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7.1.2. Germany Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7.2. Germany Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. FRANCE MARKET OVERVIEW
10.8.1. France Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.8.1.1. France External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.1.2. France Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.2. France Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11. ASIA PACIFIC NEUROMODULATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC NEUROMODULATION MARKET OVERVIEW
11.2. ASIA PACIFIC NEUROMODULATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
11.3.1. Asia Pacific External (Non-Invasive) Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
11.3.2. Asia Pacific Internal Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
11.4. ASIA PACIFIC NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.5. ASIA PACIFIC NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
11.6. JAPAN MARKET OVERVIEW
11.6.1. Japan Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.6.1.1. Japan External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.6.1.2. Japan Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.6.2. Japan Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.7. CHINA MARKET OVERVIEW
11.7.1. China Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.7.1.1. China External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.7.1.2. China Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.7.2. China Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. INDIA MARKET OVERVIEW
11.8.1. India Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.8.1.1. India External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.1.2. India Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.2. India Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. MIDDLE EAST AND AFRICA (MEA) NEUROMODULATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA (MEA) NEUROMODULATION MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA (MEA) NEUROMODULATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA (MEA) NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
12.3.1. Middle East and Africa (MEA) External (Non-Invasive) Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
12.3.2. Middle East and Africa (MEA) Internal Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
12.4. MIDDLE EAST AND AFRICA (MEA) NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.5. MIDDLE EAST AND AFRICA (MEA) NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
12.6. SOUTH AFRICA MARKET OVERVIEW
12.6.1. South Africa Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.6.1.1. South Africa External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.6.1.2. South Africa Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.6.2. South Africa Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.7. SAUDI ARABIA MARKET OVERVIEW
12.7.1. Saudi Arabia Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.7.1.1. Saudi Arabia External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.7.1.2. Saudi Arabia Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.7.2. Saudi Arabia Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. UAE MARKET OVERVIEW
12.8.1. UAE Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.8.1.1. UAE External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.8.1.2. UAE Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.8.2. UAE Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13. SOUTH AND CENTRAL AMERICA NEUROMODULATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA NEUROMODULATION MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA NEUROMODULATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
13.3.1. South and Central America External (Non-Invasive) Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
13.3.2. South and Central America Internal Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
13.4. SOUTH AND CENTRAL AMERICA NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
13.6. BRAZIL MARKET OVERVIEW
13.6.1. Brazil Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.6.1.1. Brazil External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.6.1.2. Brazil Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.6.2. Brazil Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions
15. NEUROMODULATION MARKET, KEY COMPANY PROFILES
15.1. ABBOTT
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. Product Pipeline
15.1.6. SWOT Analysis
15.1.7. Key Developments
15.2. BOSTON SCIENTIFIC CORPORATION
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. Product Pipeline
15.2.6. SWOT Analysis
15.2.7. Key Developments
15.3. INTEGER HOLDINGS CORPORATION
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. Product Pipeline
15.3.6. SWOT Analysis
15.3.7. Key Developments
15.4. MAGSTIM
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. Product Pipeline
15.4.6. SWOT Analysis
15.4.7. Key Developments
15.5. MEDTRONIC
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. Product Pipeline
15.5.6. SWOT Analysis
15.5.7. Key Developments
15.6. NEUROPACE, INC.
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Financial Overview
15.6.4. Product Portfolio
15.6.5. Product Pipeline
15.6.6. SWOT Analysis
15.6.7. Key Developments
15.7. NEUROSIGMA, INC.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. Product Pipeline
15.7.6. SWOT Analysis
15.7.7. Key Developments
15.8. NEVRO CORP.
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. Product Pipeline
15.8.6. SWOT Analysis
15.8.7. Key Developments
15.9. SYNAPSE BIOMEDICAL INC.
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. Product Pipeline
15.9.6. SWOT Analysis
15.9.7. Key Developments
15.10. SOTERIX MEDICAL INC.
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. Product Pipeline
15.10.6. SWOT Analysis
15.10.7. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. NEUROMODULATION MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Neuromodulation Market - By Technology
3.2.2. Neuromodulation Market - By End User
3.2.3. Neuromodulation Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. NEUROMODULATION MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. NEUROMODULATION MARKET - GLOBAL ANALYSIS
5.1. GLOBAL NEUROMODULATION MARKET OVERVIEW
5.2. GLOBAL NEUROMODULATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS
6. NEUROMODULATION MARKET- GLOBAL REGULATORY SCENARIO
6.1. OVERVIEW
6.2. NORTH AMERICA
6.3. EUROPE
6.4. ASIA PACIFIC
6.5. MIDDLE EAST & AFRICA
6.6. SOUTH AND CENTRAL AMERICA
7. NEUROMODULATION MARKET REVENUE AND FORECASTS TO 2027 - BY TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. EXTERNAL (NON-INVASIVE) NEUROMODULATION MARKET
7.3.1. Overview
7.3.2. External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3. Respiratory Electrical Stimulation (RES) Market
7.3.3.1. Overview
7.3.3.2. Respiratory Electrical Stimulation (RES) Market Revenue Forecasts and Analysis (US$ Mn)
7.3.4. Transcutaneous Electrical Nerve Stimulation (TENS) Market
7.3.4.1. Overview
7.3.4.2. Transcutaneous Electrical Nerve Stimulation (TENS) Market Revenue Forecasts and Analysis (US$ Mn)
7.3.5. Transcranial Magnetic Stimulation (TMS) Market
7.3.5.1. Overview
7.3.5.2. Transcranial Magnetic Stimulation (TMS) Market Revenue Forecasts and Analysis (US$ Mn)
7.4. INTERNAL NEUROMODULATION MARKET
7.4.1. Overview
7.4.2. Internal Neuromodulation Market Revenue Forecasts and Analysis (US$ Mn)
7.4.3. Deep Brain Stimulation (DBS) Market
7.4.3.1. Overview
7.4.3.2. Deep Brain Stimulation (DBS) Market Revenue Forecasts and Analysis (US$ Mn)
7.4.4. Sacral Nerve Stimulation (SNS) Market
7.4.4.1. Overview
7.4.4.2. Sacral Nerve Stimulation (SNS) Market Revenue Forecasts and Analysis (US$ Mn)
7.4.5. Gastric Electrical Stimulation (GES) Market
7.4.5.1. Overview
7.4.5.2. Gastric Electrical Stimulation (GES) Market Revenue Forecasts and Analysis (US$ Mn)
7.4.6. Spinal Cord Stimulation (SCS) Market
7.4.6.1. Overview
7.4.6.2. Spinal Cord Stimulation (SCS) Market Revenue Forecasts and Analysis (US$ Mn)
7.4.7. Vagus Nerve Stimulation (VNS) Market
7.4.7.1. Overview
7.4.7.2. Vagus Nerve Stimulation (VNS) Market Revenue Forecasts and Analysis (US$ Mn)
8. NEUROMODULATION MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. HOSPITALS MARKET
8.3.1. Overview
8.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
8.4. CLINICS MARKET
8.4.1. Overview
8.4.2. Clinics Market Revenue Forecasts and Analysis (US$ Mn)
8.5. HOME HEALTHCARE MARKET
8.5.1. Overview
8.5.2. Home Healthcare Market Revenue Forecasts and Analysis (US$ Mn)
9. NORTH AMERICA NEUROMODULATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. NORTH AMERICA NEUROMODULATION MARKET OVERVIEW
9.2. NORTH AMERICA NEUROMODULATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
9.3.1. North America External (Non-Invasive) Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
9.3.2. North America Internal Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
9.4. NORTH AMERICA NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.5. NORTH AMERICA NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
9.6. US MARKET OVERVIEW
9.6.1. US Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.6.1.1. US External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.6.1.2. US Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.6.2. US Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.7. CANADA MARKET OVERVIEW
9.7.1. Canada Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.7.1.1. Canada External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7.1.2. Canada Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7.2. Canada Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. MEXICO MARKET OVERVIEW
9.8.1. Mexico Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.8.1.1. Mexico External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.8.1.2. Mexico Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.8.2. Mexico Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10. EUROPE NEUROMODULATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. EUROPE NEUROMODULATION MARKET OVERVIEW
10.2. EUROPE NEUROMODULATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
10.3.1. Europe External (Non-Invasive) Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
10.3.2. Europe Internal Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
10.4. EUROPE NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.5. EUROPE NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
10.6. UK MARKET OVERVIEW
10.6.1. UK Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.6.1.1. UK External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.6.1.2. UK Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.6.2. UK Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.7. GERMANY MARKET OVERVIEW
10.7.1. Germany Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.7.1.1. Germany External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7.1.2. Germany Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7.2. Germany Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. FRANCE MARKET OVERVIEW
10.8.1. France Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.8.1.1. France External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.1.2. France Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.2. France Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11. ASIA PACIFIC NEUROMODULATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC NEUROMODULATION MARKET OVERVIEW
11.2. ASIA PACIFIC NEUROMODULATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
11.3.1. Asia Pacific External (Non-Invasive) Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
11.3.2. Asia Pacific Internal Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
11.4. ASIA PACIFIC NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.5. ASIA PACIFIC NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
11.6. JAPAN MARKET OVERVIEW
11.6.1. Japan Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.6.1.1. Japan External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.6.1.2. Japan Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.6.2. Japan Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.7. CHINA MARKET OVERVIEW
11.7.1. China Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.7.1.1. China External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.7.1.2. China Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.7.2. China Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. INDIA MARKET OVERVIEW
11.8.1. India Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.8.1.1. India External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.1.2. India Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.2. India Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. MIDDLE EAST AND AFRICA (MEA) NEUROMODULATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA (MEA) NEUROMODULATION MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA (MEA) NEUROMODULATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA (MEA) NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
12.3.1. Middle East and Africa (MEA) External (Non-Invasive) Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
12.3.2. Middle East and Africa (MEA) Internal Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
12.4. MIDDLE EAST AND AFRICA (MEA) NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.5. MIDDLE EAST AND AFRICA (MEA) NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
12.6. SOUTH AFRICA MARKET OVERVIEW
12.6.1. South Africa Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.6.1.1. South Africa External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.6.1.2. South Africa Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.6.2. South Africa Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.7. SAUDI ARABIA MARKET OVERVIEW
12.7.1. Saudi Arabia Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.7.1.1. Saudi Arabia External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.7.1.2. Saudi Arabia Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.7.2. Saudi Arabia Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. UAE MARKET OVERVIEW
12.8.1. UAE Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.8.1.1. UAE External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.8.1.2. UAE Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.8.2. UAE Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13. SOUTH AND CENTRAL AMERICA NEUROMODULATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA NEUROMODULATION MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA NEUROMODULATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
13.3.1. South and Central America External (Non-Invasive) Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
13.3.2. South and Central America Internal Neuromodulation Market Revenue and Forecast Analysis - By Type (US$ Mn)
13.4. SOUTH AND CENTRAL AMERICA NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA NEUROMODULATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
13.6. BRAZIL MARKET OVERVIEW
13.6.1. Brazil Neuromodulation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.6.1.1. Brazil External (Non-Invasive) Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.6.1.2. Brazil Internal Neuromodulation Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.6.2. Brazil Neuromodulation Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions
15. NEUROMODULATION MARKET, KEY COMPANY PROFILES
15.1. ABBOTT
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. Product Pipeline
15.1.6. SWOT Analysis
15.1.7. Key Developments
15.2. BOSTON SCIENTIFIC CORPORATION
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. Product Pipeline
15.2.6. SWOT Analysis
15.2.7. Key Developments
15.3. INTEGER HOLDINGS CORPORATION
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. Product Pipeline
15.3.6. SWOT Analysis
15.3.7. Key Developments
15.4. MAGSTIM
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. Product Pipeline
15.4.6. SWOT Analysis
15.4.7. Key Developments
15.5. MEDTRONIC
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. Product Pipeline
15.5.6. SWOT Analysis
15.5.7. Key Developments
15.6. NEUROPACE, INC.
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Financial Overview
15.6.4. Product Portfolio
15.6.5. Product Pipeline
15.6.6. SWOT Analysis
15.6.7. Key Developments
15.7. NEUROSIGMA, INC.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. Product Pipeline
15.7.6. SWOT Analysis
15.7.7. Key Developments
15.8. NEVRO CORP.
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. Product Pipeline
15.8.6. SWOT Analysis
15.8.7. Key Developments
15.9. SYNAPSE BIOMEDICAL INC.
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. Product Pipeline
15.9.6. SWOT Analysis
15.9.7. Key Developments
15.10. SOTERIX MEDICAL INC.
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. Product Pipeline
15.10.6. SWOT Analysis
15.10.7. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
The List of Companies
1. Abbott
2. Boston Scientific Corporation
3. Integer Holdings Corporation
4. Magstim
5. Medtronic
6. NeuroPace, Inc.
7. NeuroSigma, Inc.
8. Nevro Corp.
9. Synapse Biomedical Inc.
10. Soterix Medical Inc.
1. Abbott
2. Boston Scientific Corporation
3. Integer Holdings Corporation
4. Magstim
5. Medtronic
6. NeuroPace, Inc.
7. NeuroSigma, Inc.
8. Nevro Corp.
9. Synapse Biomedical Inc.
10. Soterix Medical Inc.